Neurobo Pharmaceuticals Inc (NRBO)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Neurobo Pharmaceuticals Inc-Aktie (NRBO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	20.74% 0.237	0.299	0.162	-	-
Operating Expenses	19.31% 7.118	5.966	4.055	-	-
Benefits Costs and Expenses	23.84% 6.951	5.613	3.98	-	-
Costs And Expenses	21.42% 6.881	5.667	3.893	3.806	2.52
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	21.42% -6.881	-5.667	-3.893	-3.806	-2.52
Net Interest Income/Expense	20.74% 0.237	0.299	0.162	-	-
Interest Income/Expense After Provision For Losses	20.74% 0.237	0.299	0.162	-	-
Income/Loss From Continuing Operations Before Tax	26.35% -6.714	-5.314	-3.818	-0.734	-2.604
Income Tax Expense/Benefit	100.00% -	-3.248	-	-	-
Income/Loss From Continuing Operations After Tax	224.98% -6.714	-2.066	-3.818	-0.734	-2.604
Net Income/Loss	26.35% -6.714	-5.314	-3.818	-0.734	-2.604
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	114.36% 5.0894	-35.45	40.61	40.47	40.47
Diluted Average Shares	114.36% 5.0894	-35.45	40.61	40.47	40.47
Basic Earnings Per Share	42.11% -1.32	-2.28	-0.09	-0.02	-0.06
Diluted Earnings Per Share	42.11% -1.32	-2.28	-0.09	-0.02	-0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%